Cartesian Therapeutics
RNAC
RNAC
57 hedge funds and large institutions have $144M invested in Cartesian Therapeutics in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
-2
Holders Change %
-3.39%
% of All Funds
1.31%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
9
Increased
31
Reduced
8
Closed
11
Calls
$44K
Puts
$7K
Net Calls
+$37K
Net Calls Change
+$39K
Top Buyers
| 1 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$6.05M |
| 2 |
AG
Artal Group
Luxembourg
|
+$4.97M |
| 3 |
BlackRock
New York
|
+$3.37M |
| 4 |
Millennium Management
New York
|
+$1.58M |
| 5 |
Man Group
London,
United Kingdom
|
+$1.43M |
Top Sellers
| 1 |
PA
Perceptive Advisors
New York
|
-$6.05M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$4.49M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.85M |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$548K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$495K |
